Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Type 2 Implementation-Effectiveness Trial of a Third Wave Virtual Reality Treatment for Youth Depression and Anxiety

NCT06894836 is registered in ClinicalTrials.gov with Orygen as lead sponsor.

NCT NCT06894836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06894836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Type 2 Implementation-Effectiveness Trial of a Third Wave Virtual Reality Treatment for Youth Depression and Anxiety
Lead sponsor
Orygen
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 1, 2025
Completion date
October 1, 2026
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression anxiety disorder